ABSA International
ABSA International

Resources with keywords: RSV



CDC’s Advisory Committee on Immunization Concludes Meeting with Joint Statement
CDC Newsroom
26 June 2025

Recommendations made by the ACIP are reviewed by the CDC Director, and if adopted, are published as official CDC/HHS recommendations in the Morbidity and Mortality Weekly Report.

Interim Evaluation of Respiratory Syncytial Virus Hospitalization Rates Among Infants and Young Children After Introduction of Respiratory Syncytial Virus Prevention Products — United States, October 2024–February 2025
CDC / MMWR
8 May 2025

Patton ME, Moline HL, Whitaker M, et al.
Interim evaluation of respiratory syncytial virus hospitalization rates among infants and young children in the United States after introduction of respiratory syncytial virus prevention products (e.g., vaccines, long-acting monoclonal antibodies).

Urgent Need to Increase Immunization Coverage for Influenza, COVID-19, and RSV and Use of Authorized/Approved Therapeutics in the Setting of Increased Respiratory Disease Activity During the 2023 – 2024 Winter Season
CDC/Health Alert Network (HAN)
Protect yourself and others from Flu, COVID-19, and RSV
CDC

CDC’s new page has county-level information on how Flu, COVID-19 and RSV viruses are trending in your area, and other useful info.

Coinfection by influenza A virus and respiratory syncytial virus produces hybrid virus particles
Nature Microbiology
24 October 2022

Haney, J., Vijayakrishnan, S., Streetley, J. et al.
The observations define a previously unknown interaction between respiratory viruses that might affect virus pathogenesis by expanding virus tropism and enabling immune evasion.

keywords: Influenza Virus, RSV
Go to Top